http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20063757-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
filingDate 2006-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a713a2b4551d2d6859a64c5b89b92a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ca8d619f5f07a8336a876f7939498ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5f3bcdc6f160a945912b31d77f7b4cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a993b165fe7f4a19382ae9b9bdf99a
publicationDate 2006-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20063757-L
titleOfInvention Substituted N-cyclohexylimidazolones with a MCH modulatory effect
abstract Substituted N-cyclohexyl heterocycles as well as the physiologically acceptable salts and physiologically functional derivatives thereof are described. Further, methods for the preparation thereof and the use of the compounds as medicaments are described. Thus, compounds of formula I are described in which the residues have the suggested meanings and the physiologically acceptable salts thereof and their preparation. The compounds cause weight loss in mammals and are, for example, suitable for birth control or therapy such as obesity or diabetes.
priorityDate 2004-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415926903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID294111

Total number of triples: 31.